TLR4 and inflammation: Collectively, the results of our study demonstrated that oral administration of 1.2 ~ 5 mg/kg of S-amlodipine led to liver inflammation and dysfunction in rats, which was induced by activation of the LPS-TLR4 pathway in the liver.